Functionalization of matrices by cyclically stretched osteoblasts through matrix targeting of VEGF
Source abstract
Abstract
Vascular endothelial growth factor A (VEGF) plays a central role in load-induced bone gain. We previously showed that increasing cyclic stretch frequency from 0.05 to 5 Hz induce parallel increased in entrapment of VEGF (mVEGF) into osteoblast secreted extracellular matrix. We ask in this study if mVEGF could be protective against apoptotic signals and biologically active in vitro on endothelial cell migration as well as in vivo on angiogenesis. We established that mechanically-induced VEGF entrapment using stretched silicone membrane was saturable after 3 exposures at high frequency stretches (5Hz). We found that mVEGF stimulates microvascular cells migration and enhanced angiogenesis more importantly than VEGF 165 controls suggesting the absence of potent anti-angiogenic factors in our functionalized matrices. Indeed we found that the anti-angiogenic factors, tissue inhibitor of metalloproteinase (TIMP2) and pigment epithelium-derived factor (PEDF) were specifically downregulated for 5 Hz stretch and that the release of these potent factors was increased for low frequency of stretch (0.05 Hz). This study qualifies high frequency cyclic stretch as an interesting approach for surfaces activation of deformable biomaterials.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cellular Mechanics and Interactions · Angiogenesis and VEGF in Cancer · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Anabolism. Low mechanical signals strengthen long bones10.1038/35088122 ↗
2. Cellular accommodation and the response of bone to mechanical loading10.1016/j.jbiomech.2004.08.017 ↗
3. Adaptation of cellular mechanical behavior to mechanical loading for osteoblastic cells10.1016/j.jbiomech.2006.09.010 ↗
4. Mechanosensitivity of human osteosarcoma cells and phospholipase C beta2 expression10.1016/j.bbrc.2005.05.088 ↗
5. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development10.1172/JCI31581 ↗
6. Fluid shear stress up-regulates vascular endothelial growth factor gene expression in osteoblasts10.1196/annals.1402.020 ↗
7. Mechanical signals modulated vascular endothelial growth factor-A (VEGF-A) alternative splicing in osteoblastic cells through actin polymerisation10.1016/j.bone.2008.02.011 ↗
8. The effect of dual frequency cyclic compression on matrix deposition by osteoblast-like cells grown in 3D scaffolds and on modulation of VEGF variant expression10.1016/j.biomaterials.2009.02.048 ↗
9. Clinical applications of angiogenic growth factors and their inhibitors10.1038/70928 ↗
10. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF10.1091/mbc.4.12.1317 ↗
11. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts10.1016/S8756-3282(01)00690-1 ↗
12. In vivo angiogenic phenotype of endothelial cells and pericytes induced by vascular endothelial growth factor-A10.1177/002215540405200105 ↗
13. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-110.1182/blood.V87.8.3336.bloodjournal8783336 ↗
14. Osteoblasts and osteoclasts express PEDF, VEGF-A isoforms, and VEGF receptors: possible mediators of angiogenesis and matrix remodeling in the bone10.1016/j.bbrc.2004.02.076 ↗
15. Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone10.1038/sj.bjc.6602417 ↗
16. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts10.1016/S0014-5793(00)01520-9 ↗
17. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals10.1006/jmcc.1996.0365 ↗
18. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells10.1074/jbc.273.21.13313 ↗
19. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation10.1074/jbc.273.46.30336 ↗
20. Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells10.1083/jcb.200906044 ↗
21. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors10.1083/jcb.200409115 ↗
22. The phosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) by engineered surfaces with electrostatically or covalently immobilized VEGF10.1016/j.biomaterials.2009.05.030 ↗
23. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects10.1359/jbmr.060120 ↗
24. Vascular endothelial growth factor gene-activated matrix (VEGF 165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects10.1359/JBMR.050701 ↗
25. Interpolation revisited10.1109/42.875199 ↗
26. Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors10.1021/jm990345w ↗
27. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity10.1161/01.RES.0000026420.22406.79 ↗
28. The role of heparan sulphate proteoglycans in angiogenesis10.1042/BST0340451 ↗
29. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase10.1074/jbc.275.14.10661 ↗
30. Vascular physiology. A family of angiogenic peptides10.1038/329671a0 ↗
31. Signal relays in the VEGF system10.2741/Ortéga ↗
32. VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA10.1016/j.yexcr.2005.05.022 ↗
33. Polymeric system for dual growth factor delivery10.1038/nbt1101-1029 ↗
34. MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing10.1002/jbm.a.20091 ↗
35. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion10.1158/1535-7163.MCT-05-0179 ↗
36. Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases10.1074/jbc.M307688200 ↗
37. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism10.1016/S0092-8674(03)00551-8 ↗
38. Pigment epithelium-derived factor as a multifunctional antitumor factor10.1007/s00109-006-0111-z ↗
39. Characterization of PEDF: a multi-functional serpin family protein10.1002/jcb.22072 ↗
40. A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus10.1073/pnas.082110999 ↗
41. Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels10.2353/ajpath.2008.070181 ↗
42. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis10.1172/JCI18420 ↗
43. Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia10.1096/fj.06-6568fje ↗
44. Adsorption of vascular endothelial growth factor to two different apatitic materials and its release10.1023/A:1011286818733 ↗
45. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways10.1074/jbc.M103213200 ↗